Machine learning-based clinical decision support using laboratory data

Abstract

Artificial intelligence (AI) and machine learning (ML) are becoming vital in laboratory medicine and the broader context of healthcare. In this review article, we summarized the development of ML models and how they contribute to clinical laboratory workflow and improve patient outcomes. The process of ML model development involves data collection, data cleansing, feature engineering, model development, and optimization. These models, once finalized, are subjected to thorough performance assessments and validations. Recently, due to the complexity inherent in model development, automated ML tools were also introduced to streamline the process, enabling non-experts to create models. Clinical Decision Support Systems (CDSS) use ML techniques on large datasets to aid healthcare professionals in test result interpretation. They are revolutionizing laboratory medicine, enabling labs to work more efficiently with less human supervision across pre-analytical, analytical, and post-analytical phases. Despite contributions of the ML tools at all analytical phases, their integration presents challenges like potential model uncertainties, black-box algorithms, and deskilling of professionals. Additionally, acquiring diverse datasets is hard, and models’ complexity can limit clinical use. In conclusion, ML-based CDSS in healthcare can greatly enhance clinical decision-making. However, successful adoption demands collaboration among professionals and stakeholders, utilizing hybrid intelligence, external validation, and performance assessments.

Immunophenotype signatures in acute leukemias unveiled by integrative systems immunology

“…Consistent with previous analyses, we were able to effectively capture cell distribution patterns, cluster classification, variations in marker expression intensity, and differences between patient groups in our cohort. These findings emphasize the power of bioinformatics tools in analyzing flow cytometry data to differentiate between distinct AL subtypes and controls (Beyrend et al, 2018;Cheung et al, 2022;Çubukçu et al, 2023;Melsen et al, 2020;Montante & Brinkman, 2019;Saeys et al, 2016). The ability to identify leukemia-specific cellular populations and visualize differentiation trajectories can significantly optimize the diagnostic process (Ng et al, 2024;Nguyen et al, 2023;Seifert et al, 2023;Simonson et al, 2022).…”

Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma

“…In recent years, machine learning-based AI models attracted increasing attention in clinical practice [ 14 , 20 , 21 ]. Especially, AI-based technologies have made a significant contribution to the field of cancer research [ 21 ].…”

Optimizing Machine Learning Models for Urinary Tract Infection Diagnostics: A Comparative Study of Logistic Regression and Random Forest

“…These models can integrate and analyze complex, multidimensional datasets, offering insights and predictive capabilities far beyond traditional statistical approaches [16], [17], [18]. Despite their potential, the optimal application of these models in UTI diagnostics requires careful tuning and validation to ensure maximum accuracy and utility in real-world settings [19], [20], [21].…”